MYC-Mediated USP39 Upregulation Stabilizes SRSF1 in Pancreatic Cancer

Molecular Cancer Research · Published 2026-06-11 · DOI 10.1158/1541-7786.mcr-25-1104

Free full text

Authors (10)

Benteng Ma, Xin Zhang, Alexander J. Kral, Neelu Singh, Astrid Deschênes, Paolo Cifani, Youngkyu Park, David A. Tuveson, Adrian R. Krainer, Ledong Wan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Ma, B., Zhang, X., Kral, A., et al. (2026). MYC-Mediated USP39 Upregulation Stabilizes SRSF1 in Pancreatic Cancer. Molecular Cancer Research. https://doi.org/10.1158/1541-7786.mcr-25-1104

Related articles

• Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer · Molecular Cancer Research · 2026 · Same journal
• The PON1-NDUFA4 axis maintains mitochondrial respiratory fitness and drives lenvatinib tolerance in hepatocellular carcinoma · Molecular Cancer Research · 2026 · Same journal
• Selected Articles from This Issue · Molecular Cancer Research · 2026 · Same journal
• C1QBP–STAT1 Interaction Promotes Activation of the c-Myc–CHK1/CHK2 Signaling Axis and Radioresistance in Lung Cancer · Molecular Cancer Research · 2026 · Same journal
• Selected Articles from This Issue · Molecular Cancer Research · 2026 · Same journal
• Comprehensive Multi-Omic Profiling of Desmoplastic Small Round Cell Tumors Identifies Targetable Pathways with Therapeutic Opportunities · Molecular Cancer Research · 2026 · Same journal
• Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of ALK Fusion Gene-Associated Renal Tumorigenesis · Molecular Cancer Research · 2025 · Same journal
• The Trifecta of Polo-Like Kinases, Cancer, and the Immune System: Emerging Intersections and Therapeutic Insights · Molecular Cancer Research · 2026 · Same journal
• SF3B4-QKI Splicing Complex Generates Circ-FNDC3B and Mediates Breast Cancer Inhibition · Molecular Cancer Research · 2026 · Same journal
• 3beta-HSD1-mediated steroid back-conversion maintains androgen signaling in prostate cancer · Molecular Cancer Research · 2026 · Same journal